Report submitted to Delhi HC shows over 16,500 cases with claim value of about Rs 498 lakh cr are pending in 3 Debts Recovery Tribunals. HC asks finance ministry to consider report.
Advice comes at a time when India accounts for a 5th of global generic drug supply & 40% of generics used in US. However, this strength in finished formulations relies on imported ingredients.
It’s easy to understand why the government can’t speak the hard truth. When this war ends, as all wars do, India’s interests will lie with both the winner and the loser.
COMMENTS